Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04131946 · ClinicalTrials.gov registry record · NA
Cancer Screening; Access; Awareness; Navigation
A NA study of Colorectal Cancer Screening, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 2
- Study locations
NCT04131946: Completed NA study of Colorectal Cancer Screening, sponsored by University of Illinois at Chicago.
NCT04131946 is a NA study of Colorectal Cancer Screening that has completed, run by University of Illinois at Chicago. The registered enrollment target is 37 participants, below the 5,881-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04131946, a NA study of Colorectal Cancer Screening, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 2
- Study locations
Study Summary
To assess the feasibility and efficacy of community-based Colorectal Cancer (CRC) screening intervention in increasing CRC screening rates To evaluate individual-level knowledge related to CRC screening and risk factors To characterize individual -level facilitators and barriers to engaging in CRC screening and related diagnostic tests and treatment when applicable.
Primary Outcome
Evaluate feasibility and efficacy of conducting a community-based navigation program for CRC screening. In both arms of the study, we will examine the number of participants provided with health education about colorectal cancer, number of FITs distributed, and number of FITs returned. We will summarize the number of persons screened positive and negative, and determine the proportion of positive screening who are referred to clinical care, and at the Mile Square South Shore and Englewood sites
Conditions Studied
Interventions
- OTHER Community-Based (Intervention Arm)
Study Locations (2)
Illinois
- University of Illinois - Chicago
- Mile Square Health Center - Englewood - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2019-11-12 |
| Est. Completion | 2021-12-20 |
| Phase | NA |
What the finished NCT04131946 record still lists
NCT04131946 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 5,881-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which Community-Based (Intervention Arm) is the first listed.
NCT04131946 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04131946 about?
NCT04131946 is a clinical study titled "Cancer Screening; Access; Awareness; Navigation". To assess the feasibility and efficacy of community-based Colorectal Cancer (CRC) screening intervention in increasing CRC screening rates To evaluate individual-level knowledge related to CRC screening and risk factors To characterize individual -level facilitators and barriers to engaging in CRC s...
What is the current status of trial NCT04131946?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2019-11-12. Estimated completion is 2021-12-20.
What conditions does trial NCT04131946 study?
This clinical trial studies the following conditions: Colorectal Cancer Screening.
What interventions are being tested in trial NCT04131946?
The interventions under investigation include: Community-Based (Intervention Arm) (OTHER).
Who is sponsoring clinical trial NCT04131946?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04131946 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04131946's enrollment target sits among peer trials
37 20th of 19 the lowest of 19 other Colorectal Cancer Screening trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Protect Your Colon™ on CRC Screening
RECRUITING · NA
-
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
RECRUITING · NA
-
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
RECRUITING · NA
-
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
RECRUITING · NA
-
Test Up Now Education Program
COMPLETED · NA
-
Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI